This content is not available in your region

Switzerland buys Pfizer's COVID-19 antiviral Paxlovid

Switzerland buys Pfizer's COVID-19 antiviral Paxlovid
Switzerland buys Pfizer's COVID-19 antiviral Paxlovid   -   Copyright  Thomson Reuters 2022
By Reuters

BERLIN – Switzerland signed a contract to buy Pfizer’s anti-viral drug Paxlovid to treat Covid-19, it said on Friday.

The European country said it had signed a contract to buy 12,000 packages and first treatments for certain at-risk patients would start this month.